1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Global Analysis of Ebola Disease : Expenditure on Prevention and Containment to Soar towards $5.9 Billion by End of 2016

  • November 2014
  • 37 pages
  • Frost & Sullivan
Report ID: 2488509

Summary

Table of Contents

Key Findings

•The Ebola virus is being contained in many of the developed nations such as the United States, Spain, and France due to better infrastructure and the availability of rapid tests and quality treatment.
•The porous borders of Western Africa and its neighboring countries still pose the threat of a global Ebola epidemic.
•China and India pose the most risk because of their large stakes in Africa, and due to increasing trade interactions and open sea ports, the threat of Ebola transmission in these countries is high.
•Frost & Sullivan’s optimistic prediction foresees a decrease in the number of Ebola cases globally in late 2015 through early 2016 due to the commercial availability of approved vaccines and treatment in the hard-hit nations of Africa.
•The containment of the disease is impeded by lack of healthcare workers and availability of treatment.
•The urgent demand for sensitive and rapid tests in detecting and containing this disease will spur the molecular methods market.
•The immunodiagnostics market will also continue to grow due to its cost effectiveness, especially for initial screening of Ebola.
•Frost & Sullivan predicts that if the Ebola crisis is not contained, despite best efforts, the global burden will reach $xx billion by the end of 2016.

What is Ebola?

•Ebola virus disease, also known as Ebola hemorrhagic fever, has threatened humanity since its initial occurrence in 1976. It is often severe and fatal in humans.
•The virus was initially transmitted from animals, such as bats, to humans.
•According to the World Health organization (WHO), the disease spreads among people when one comes in contact with an infected person’s bodily fluids (e.g., blood and secretions such as saliva and sweat). Infection also occurs by indirect contact with these fluids, meaning this disease can be spread by surfaces and materials (e.g., bedding, clothing) contaminated by these fluids. The current 2014 outbreak has been the largest and most complex since 1976.
•The reason Ebola is such a hard disease to diagnose and treat is because the virus changes the RNA in our cells and replicates unique to individuals.
•The disease is not infectious until the onset of symptoms, which has an incubation period of xx to xx days.
•Initial symptoms include: fever, fatigue, muscle pain, headache, and sore throat.
•Later stage symptoms include: vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and, in some cases, both internal and external bleeding.
•No proven standardized treatment for this disease currently exist.
•Three main vaccines are in the pipeline developed by GlaxoSmithKline, Johnson & Johnson, and New Link Genetics Corporation to enable containment and preventative measures.

Key Questions This Study Will Answer

What is the outlook for the Ebola diagnostics market ?
What are the key predictions for new Ebola cases and the associated burden in 2015 and 2016?
What are some of the diagnostic products and drug/vaccines in the pipeline to help contain this disease?
What is the potential global expenditure due to the prevalence of Ebola?

CEO’s Perspective

GlaxoSmithKline appears at the forefront of vaccine development and will be the market leader by mid-2015.
Corgenix will dominate the Ebola diagnostics market due to rapid TAT after its launch in 2015, provided the disease prevails.
More immunodiagnostics kits will be sold due to their cost effectiveness, especially in developing nations.
If Ebola is transmitted to East Asia, the global market in 2015 for molecular methods and immunodiagnostics will reach $xx million and $xx million respectively.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 43500
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 68-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.